| Name | Title | Contact Details |
|---|
NeuSpera Medical will deliver a liberating alternative treatment for certain patients trapped by the symptoms of their disease.
MY01 is a state-of-the-art medical device geared towards aiding in the detection of Compartment Syndrome (CS); a limb-threatening muscle condition that occurs within 48 hours following trauma. Currently, ACS is diagnosed based on subjective and unreliable outcomes like pain (known as 6 P`s), which when present cannot confirm the diagnosis in time for effective intervention. This leads to increased complications (muscle necrosis/amputation) and costs the US healthcare system more than $2.25 B annually. MY01 is capitalizing on a proven correlation between sustained increase in Intramuscular pressures and ACS for objective, early diagnosis. MY01 operationalizes muscular pressure monitoring into a simple, accurate single-use device. MY01. The simple solution to a dangerous problem.
Merlin Development Inc is a Minneapolis, MN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Biohit is a Neptune, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Knueppel HealthCare Services is a Milwaukee, WI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.